R. Bick

发表

Introduction to thrombosis proficient and cost-effective approaches to thrombosis.

R. Bick, 2003, Hematology/oncology clinics of North America.

Clinical Aspects of Heparin-Induced Thrombocytopenia and Thrombosis and other Side Effects of Heparin Therapy

E. Frenkel, R. Bick, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Oral Anticoagulants in Thromboembolic Disease

R. Bick, 1995 .

OF NORTH AMERICA Controversies and Unresolved Issues in Antiphospholipid Syndrome Pathogenesis and Management

J. Fareed, R. Bick, W. Baker, 2022 .

Hereditary and Acquired Thrombophilic Disorders

R. Bick, 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Disseminated Intravascular Coagulation: Objective Clinical and Laboratory Diagnosis, Treatment, and Assessment of Therapeutic Response

R. Bick, 1996, Seminars in thrombosis and hemostasis.

Low Molecular Weight Heparins : Basic and Applied Considerations

D. Hoppensteadt, J. Fareed, Q. Ma, 2004 .

Unfractionated and Low-Molecular-Weight Heparins, Basic Mechanism of Action and Pharmacology

D. Hoppensteadt, J. Fareed, Q. Ma, 2003 .

The Clinical Significance of Fibrinogen Degradation Products

R. Bick, 1982, Seminars in thrombosis and hemostasis.

Heparin, low-molecular-weight heparins, and heparin pentasaccharide: basic and clinical differentiation.

D. Hoppensteadt, J. Fareed, J. Walenga, 2003, Hematology/oncology clinics of North America.

Syndromes of Thrombosis and Hypercoagulability: Congenital and Acquired Thrombophilias

H. Kaplan, R. Bick, 1998 .

Syndromes of thrombosis and hypercoagulability. Congenital and acquired causes of thrombosis.

H. Kaplan, H. Kaplan, R. Bick, 1998, The Medical clinics of North America.

Bick State-ofthe-Art Review : Antiphospholipid Thrombosis Syndromes

R. Bick, Thromb Hemost, 2007 .

State-of-the-Art Review: Antiphospholipid Thrombosis Syndromes

R. Bick, 2001 .

Antiphospholipid-thrombosis syndromes.

E. Frenkel, B. Arun, R. Bick, 2003, Haemostasis.

The Antiphospholipid Thrombosis Syndromes: A Common Multidisciplinary Medical Problem

R. Bick, 1997 .

Antiphospholipid and thrombosis syndromes.

R. Bick, W. Baker, 1994, Seminars in thrombosis and hemostasis.

New Anticoagulants for the Cardiovascular Patient

J. Fareed, R. Pifarré, J. Walenga, 1995 .

Current Developments in Anticoagulant and Antithrombotic Agents

J. Fareed, J. Walenga, D. Hoppensteadt, 1999 .

Antithrombin Agents: The New Class of Anticoagulant and Antithrombotic Drugs

D. Hoppensteadt, J. Fareed, J. Walenga, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Antithrombin agents as anticoagulants and antithrombotics. Implications in drug development.

D. Hoppensteadt, J. Fareed, J. Walenga, 1998, The Medical clinics of North America.

Controversies and unresolved issues in antiphospholipid syndrome pathogenesis and management.

J. Fareed, R. Bick, W. Baker, 2008, Hematology/oncology clinics of North America.

Vascular thrombohemorrhagic disorders: hereditary and acquired.

R. Bick, 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Current trends in the development of anticoagulant and antithrombotic drugs.

D. Hoppensteadt, J. Fareed, J. Walenga, 1994, The Medical clinics of North America.

Argatroban and Lepirudin: Clinical Trials to Clinical Practice

J. Fareed, H. Messmore, J. Walenga, 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Hypercoagulability and thrombosis.

R. Bick, 1994, The Medical clinics of North America.

Disseminated intravascular coagulation. Objective laboratory diagnostic criteria and guidelines for management.

R. Bick, 1994, Clinics in laboratory medicine.

Disseminated intravascular coagulation current concepts of etiology, pathophysiology, diagnosis, and treatment.

R. Bick, 2003, Hematology/oncology clinics of North America.

Hypercoagulability and thrombosis.

K. Ucar, R. Bick, Kalust Ucar, 1992, Hematology/oncology clinics of North America.

A new two-stage functional assay for antithrombin-III (heparin cofactor): clinical and laboratory evaluation.

I. Kovács, R. Bick, L. Fekete, 1976, Thrombosis research.

Coagulation Abnormalities in Malignancy: A Review

R. Bick, 1992, Seminars in thrombosis and hemostasis.

Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other side effects of heparin therapy.

J. Walenga, R. Bick, Jeanine M. Walenga, 1998, The Medical clinics of North America.

SEMINARS IN THROMBOSIS AND HEMOSTASIS Bibliothek Mund « n

B. Furie, D. Stirling, T. Barrowcliffe, 2011 .

Fondaparinux: a synthetic heparin pentasaccharide as a new antithrombotic agent

M. Samama, J. Fareed, W. Jeske, 2002, Expert opinion on investigational drugs.

Anticardiolipin antibodies and thrombosis.

R. Bick, W. Baker, 1992, Hematology/oncology clinics of North America.

Long-Term Outpatient Dalteparin (Fragmin) Therapy for Arterial and Venous Thrombosis: Efficacy and Safety—A Preliminary Report

J. Rice, R. Bick, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Deep Vein Thrombosis: Prevalence of Etiologic Factors and Results of Management in 100 Consecutive Patients

R. Bick, W. Baker, J. Jakway, 1992, Seminars in thrombosis and hemostasis.

Laboratory modalities for assessing hemostasis during cardiopulmonary bypass.

R. Bick, L. Fekete, 2008, Seminars in thrombosis and hemostasis.

Clinical Relevance of Antithrombin III

R. Bick, 1982, Seminars in thrombosis and hemostasis.

Cancer-associated thrombosis.

R. Bick, 2003, The New England journal of medicine.

Survival of heparins, oral anticoagulants, and aspirin after the year 2010.

D. Hoppensteadt, J. Fareed, C. Adiguzel, 2008, Seminars in thrombosis and hemostasis.

Recurrent Miscarriage Syndrome and Infertility Due to Blood Coagulation Protein/Platelet Defects: A Review and Update

D. Hoppensteadt, R. Bick, 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Prothrombin G20210A mutation, antithrombin, heparin cofactor II, protein C, and protein S defects.

R. Bick, 2003, Hematology/oncology clinics of North America.

Disorders of Hemostasis and Thrombosis

R. Bick, 1985 .

Antithrombotic therapy: current practice and future trends.

R. Bick, 2005, Hematology/oncology clinics of North America.

Useful laboratory tests for studying thrombogenesis in acute cardiac syndromes.

D. Hoppensteadt, J. Fareed, O. Iqbal, 1998, Clinical chemistry.

Disseminated Intravascular Coagulation

E. Frenkel, B. Arun, R. Bick, 1999, Pathophysiology of Haemostasis and Thrombosis.

Increased levels of inflammatory mediators in lung cancer and their modulation by oral anticoagulant treatment.

D. Hoppensteadt, J. Fareed, O. Iqbal, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MolecularMarkers of HemostaticDisorders:Implicationsin the Diagnosis and Therapeutic Managementof Thromboticand BleedingDisorders

R. Bick, G. Squillaci, 1983 .

International consensus recommendations. Summary statement and additional suggested guidelines. European Consensus Conference, November 1991. American College of Chest Physicians consensus statement of 1995. International Consensus Statement, 1997.

R. Bick, S. Haas, 1998, The Medical clinics of North America.

Hematology : clinical and laboratory practice

R. Bick, 1993 .

Hydroxyethyl starch versus albumin in cardiopulmonary bypass prime solutions.

C. Saunders, R. Bick, L. Carlisle, 1983, The Annals of thoracic surgery.

The rheological changes after cesarean section: The influence of low molecular weight or unfractionated heparin on the rheological properties of blood.

W. Rath, L. Heilmann, R. Bick, 2007, Clinical hemorheology and microcirculation.

Pitfalls in Warfarin Therapy

J. Fareed, H. Messmore, R. Bick, 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Antiphospholipid and Thrombosis Syndromes

R. Bick, W. Baker, 1994, The Medical clinics of North America.

Preliminary report on the use of CCNU (NSC-79037), adriamycin (NSC-123127), and hexamethylmelamine (NSC-13875) in carcinoma of the lung.

R. Bick, T. Nealon, R. Frelick, 1976, Cancer treatment reports.

Piracetam: A New Platelet Suppressing Drug

J. Fareed, R. Bick, V. Skondia, 1981 .

The Immunogenic Potential of Generic Version of Low-Molecular-Weight Heparins May Not be the Same as the Branded Products

A. Nicolaides, S. Goldhaber, A. Sasahara, 2008, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Hemostasis Defects Associated with Cardiac Surgery, Prosthetic Devices, and Other Extracorporeal Circuits

R. Bick, 1985, Seminars in thrombosis and hemostasis.

Antiphospholipid Syndrome and Thrombosis

R. Bick, W. Baker, 1999, Seminars in thrombosis and hemostasis.

State-of-the-Art Review Hereditary and Acquired Thrombophilic Disorders

R. Bick, 2006 .

Disseminated Intravascular Coagulation: Pathophysiological Mechanisms and Manifestations

R. Bick, 1998, Seminars in thrombosis and hemostasis.

Fetal Wastage Syndrome due to Blood Protein/Platelet Defects: Results of Prevalence Studies and Treatment Outcome with Low-Dose Heparin and Low-Dose Aspirin

B. M. Cohen, J. Madden, R. Bick, 1995 .

The clinical spectrum of antiphospholipid syndrome.

R. Bick, W. Baker, 2008, Hematology/oncology clinics of North America.

Drug-induced alterations of hemostasis and fibrinolysis.

J. Fareed, P. Bacher, R. Bick, 1992, Hematology/oncology clinics of North America.

State-of-the-Art-Review : Thrombogenesis in Myocardial Infarction and Related Syndromes: The Role of Molecular Markers in Diagnosis and Management

D. Hoppensteadt, J. Fareed, B. Lewis, 1999 .

Comparison of Immunogenic Potentials of Bovine Thrombin Preparations

D. Hoppensteadt, J. Fareed, C. Adiguzel, 2009, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Physiology of hemostasis.

G. Murano, R. Bick, 1994, Clinics in laboratory medicine.

Anemia of malignancy.

E. Frenkel, C. Rutherford, R. Bick, 1996, Hematology/oncology clinics of North America.

Treatment options for patients who have antiphospholipid syndromes.

R. Bick, W. Baker, 2008, Hematology/oncology clinics of North America.

Evaluation of a New Hydroxyethyl Starch, Preparation (Hextend™) on Selected Coagulation Parameters

R. Bick, 1995 .

Antiphospholipid-Thrombosis Syndromes

E. Frenkel, B. Arun, R. Bick, 1999, Pathophysiology of Haemostasis and Thrombosis.

Bleeding times, platelet adhesion, and aspirin.

R. Bick, W. Schmalhorst, T. Adams, 1977, American journal of clinical pathology.

Acquired Defects of Fibrinolysis Associated with Thrombosis

D. Hoppensteadt, J. Fareed, W. Jeske, 1999, Seminars in thrombosis and hemostasis.

Disseminated intravascular coagulation.

R. Bick, 1977, Hematology/oncology clinics of North America.

Recurrent miscarriage syndrome and infertility caused by blood coagulation protein or platelet defects.

R. Bick, 2000, Hematology/oncology clinics of North America.

Thrombophilic Causes of Retinal Vascular Thrombosis: Etiology and Treatment Outcomes

R. Bick, Hitaf Alfar, Christine Goedecke, 2002, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

State-of-the-Art Review : Disseminated Intravascular Coagulation: Objective Criteria for Clinical and Laboratory Diagnosis and Assessment of Therapeutic Response

R. Bick, 1995 .

Disseminated intravascular coagulation. Objective criteria for diagnosis and management.

R. Bick, 1994, The Medical clinics of North America.

Role of antithrombin III in clinical management of pulmonary embolization.

R. Bick, 1984, The American journal of medicine.

Antithrombins And Coronary Artery Disease

R. Bick, D. Faulstick, 1984, Thrombosis and Haemostasis.

COMPARISON OF ANTITHROMBIN III ASSAYS: METHODS OF CHOICE

R. Bick, 1983 .

Thrombotic Thrombocytopenic Purpura: An Extended Editorial

R. Bick, R. Nalbandian, R. Henry, 2008, Seminars in thrombosis and hemostasis.

Fibrinolytic activity in acute myocardial infarction.

R. Bick, E. Shanbrom, R. Bishop, 1972, American journal of clinical pathology.

Thorotrast-Induced Angiosarcoma Complicated by Disseminated Intravascular Coagulation and Microangiopathic Hemolytic Anemia: Case Report and Review

R. Bick, W. Baker, David P. Schale, 1995 .

The Available Low Molecular Weight Heparin Preparations Are Not the Same

J. Fareed, W. Jeske, J. Walenga, 1997 .

Contaminants in heparins continue to be unfolded.

D. Hoppensteadt, J. Fareed, R. Bick, 2008, International angiology : a journal of the International Union of Angiology.

Contaminant in the Recalled Unfractionated Heparin Preparations: Where is the Problem?

D. Hoppensteadt, J. Fareed, V. Bansal, 2008, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

L-Asparaginase-Provoked Seizures as Singular Expression of Central Nervous Toxicity

E. Frenkel, R. Bick, M. Hamdan, 2000, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

An update on heparins at the beginning of the new millennium.

D. Hoppensteadt, R. Bick, J. Fareed, 2000, Seminars in thrombosis and hemostasis.

Low Molecular Weight Heparins: Differences and Similarities in Approved Preparations in the United States

J. Fareed, R. Bick, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Generic low-molecular-weight heparins: some practical considerations.

D. Hoppensteadt, J. Fareed, W. Jeske, 2004, Seminars in thrombosis and hemostasis.

Molecular Markers of Hemostatic Activation: Applications in the Diagnosis of Thrombosis and Vascular and Thrombotic Disorders

D. Hoppensteadt, J. Fareed, R. Bick, 1995 .

Alterations of hemostasis associated with cardiopulmonary bypass.

R. Bick, W. Schmalhorst, N. Arbegast, 1976, Thrombosis research.

Hemostatic Defects Induced by Cardiopulmonary Bypass

R. Bick, W. Schmalhorst, N. Arbegast, 1975, Vascular surgery.

Syndromes of disseminated intravascular coagulation in obstetrics, pregnancy, and gynecology. Objective criteria for diagnosis and management.

R. Bick, 2000 .

Disseminated Intravascular Coagulation and Related Syndromes: A Clinical Review

R. Bick, 1988, Seminars in thrombosis and hemostasis.

Cardiopulmonary Bypass Hemorrhage: Aggravation by Pre-Op Ingestion of Antiplatelet Agents

R. Bick, L. Fekete, 1979 .

Hereditary Plasma Protein Disorders

R. Bick, 2019, Basic Concepts of Hemostasis and Thrombosis.

Impact of Automation on the Quantitation of Low Molecular Weight Markers of Hemostatic Defects

J. Fareed, H. Messmore, J. Walenga, 1983, Seminars in thrombosis and hemostasis.

Molecular markers of hemostatic disorders: implications in the diagnosis and therapeutic management of thrombotic and bleeding disorders.

J. Fareed, J. Walenga, R. Bick, 1983, Clinical chemistry.

Adriamycin and fibrinolysis.

W. Wilson, R. Bick, L. Fekete, 1976, Thrombosis research.

Platelet function defects associated with hemorrhage or thrombosis.

R. Bick, 1994, The Medical clinics of North America.

Acquired platelet function defects.

R. Bick, 1992, Hematology/oncology clinics of North America.

Coagulation abnormalities in patients with precocious coronary artery thrombosis and patients failing coronary artery bypass grafting and percutaneous transcoronary angioplasty.

R. Bick, W. Baker, Y. Ismail, 1993, Seminars in Thrombosis and Hemostasis.

Syndromes of Hypercoagulability and Thrombosis: A Review

M. Pegram, R. Bick, M. Pegram, 1994, Seminars in thrombosis and hemostasis.

Diagnostic Efficacy of a Simple Radioimmunoassay Test for Fibrinogen/Fibrin Fragments Containing the Bβ 15-42 Sequence

G. Mariani, J. Fareed, H. Messmore, 1984, Seminars in thrombosis and hemostasis.

Alterations of Hemostasis Associated With Cardiopulmonary Bypass: Pathophysiology, Prevention, Diagnosis, and Management

R. Bick, 1976, Seminars in thrombosis and hemostasis.

Diagnostic efficacy of the D-dimer assay in disseminated intravascular coagulation (DIC).

R. Bick, W. Baker, 1992, Thrombosis research.

Vascular Disorders Associated with Thrombohemorrhagic Phenomena

R. Bick, 2008, Seminars in thrombosis and hemostasis.

Disseminated Intravascular Coagulation and Blood Component Therapy

R. Bick, W. Schmalhorst, L. Fekete, 2003, Transfusion.

Disseminated Intravascular Coagulation: A Review of Etiology, Pathophysiology, Diagnosis, and Management: Guidelines for Care

R. Bick, 2002, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Antithrombin III(AT-III) as a diagnostic aid in disseminated intravascular coagulation.

W. Wilson, R. Bick, L. Fekete, 1977, Thrombosis research.

Product Individuality of Commercially Available Low-Molecular-Weight Heparins and Their Generic Versions: Therapeutic Implications

D. Hoppensteadt, J. Fareed, W. Jeske, 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Acquired Circulating Anticoagulants And Defective Hemostasis In Malignant Paraprotein Disorders

R. Bick, 2019, Basic Concepts of Hemostasis and Thrombosis.

Disseminated intravascular coagulation and related syndromes: Etiology, pathophysiology, diagnosis, and management

R. Bick, 1978, American journal of hematology.

Prothrombin complex concentrate: Use in controlling the hemorrhagic diathesis of chronic liver disease

R. Bick, E. Shanbrom, W. Schmalhorst, 1975, The American Journal of Digestive Diseases.

Hereditary Hemorrhagic Telangiectasia And Disseminated Intravascular Coagulation: A New Clinical Syndrome

R. Bick, 1981, Thrombosis and Haemostasis.

State-of-the-Art Review: Vascular Thrombohemorrhagic Disorders: Hereditary and Acquired

R. Bick, 2001 .

Fibrinolytic potential in polycythemia rubra vera.

R. Bick, 1974, Beitrage zur Pathologie.

Disseminated intravascular coagulation syndromes.

R. Bick, L. Kunkel, 1992, International journal of hematology.

Thrombosis and hemorrhage in oncology patients.

E. Frenkel, J. Strauss, R. Bick, 1996, Hematology/oncology clinics of North America.

Platelet Function Defects: A Clinical Review

R. Bick, 1992, Seminars in thrombosis and hemostasis.

Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy

E. Frenkel, R. Bick, W. Baker, 2006 .

Reduced Immunogenic Potential of Membrane Filtered Bovine Thrombin Preparations for Hemostatic Application

J. Cunanan, D. Hoppensteadt, J. Fareed, 2009, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Antigenic (Immunogenic) Profiling of Bovine Thrombin and its Purified Forms

H. Messmore, J. Walenga, R. Bick, 2008, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

A Clinical Comparison Of Chromogenic, Fluorometric, And Natural (Fibrinogen) Substrate Assays For Determination Of Antithrombin-III

R. Bick, B. McClain, 1981, Thrombosis and Haemostasis.

Disseminated Intravascular Coagulopathy (DIC): Pathophysiology, Laboratory Diagnosis, and Management

R. Bick, L. Pechet, S. Senno, 2000 .

Current perspectives in antithrombotic therapy

D. Hoppensteadt, J. Fareed, O. Iqbal, 2001, Hämostaseologie.

Laboratory Evaluation of Antithrombin III: A Critical Overview of Currently Available Methods for Antithrombin III Measurements

J. Fareed, H. Messmore, J. Walenga, 1982, Seminars in thrombosis and hemostasis.

Hematological complications in obstetrics, pregnancy, and gynecology

E. Frenkel, R. Sarode, R. Bick, 2006 .

Hyperfibrinolysis in cirrhosis.

R. Bick, P. Pises, B. Siegel, 1973, The American journal of gastroenterology.

Antithrombin-III as a Diagnostic AID in Disseminated Intravascular Coagulation

W. Wilson, R. Bick, L. Fekete, 1977 .

DISSEMINATED INTRAVASCULAR COAGULATION: A CLINICAL/LABORATORY STUDY OF 48 PATIENTS

R. Bick, 1981, Annals of the New York Academy of Sciences.

Treatment of Hereditary and Acquired Thrombophilic Disorders

R. Bick, W. Baker, 1999, Seminars in thrombosis and hemostasis.

Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use.

E. Frenkel, D. Hoppensteadt, J. Fareed, 2005, Hematology/oncology clinics of North America.

Thromboprophylaxis and thrombosis in medical, surgical, trauma, and obstetric/gynecologic patients.

S. Haas, R. Bick, 2003, Hematology/oncology clinics of North America.

Evidence for a new activation phase clotting abnormality in a patient with the Hughes-Stoven syndrome.

R. Bick, T. Adams, L. Goldberg, 1974, Beitrage zur Pathologie.

Surgical hemostasis with a factor XL-containing concentrate.

R. Bick, K. Radack, T. Adams, 1974, JAMA.

The antiphospholipid-thrombosis syndromes. Fact, fiction, confusion, and controversy.

R. Bick, 1993, American journal of clinical pathology.

Laboratory evaluation of the antiphospholipid syndrome.

D. Hoppensteadt, J. Fareed, H. Messmore, 2008, Hematology/oncology clinics of North America.

Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other adverse effects of heparin-type therapy.

E. Frenkel, J. Walenga, R. Bick, 2003, Hematology/oncology clinics of North America.

Daunomycin and fibrinolysis.

W. Wilson, G. Murano, R. Bick, 1976, Thrombosis research.

Malaria transmission among narcotic addicts. A report of ten cases and review of the literature.

R. Bick, J. Anhalt, 1971, California medicine.

Development of generic low molecular weight heparins: a perspective.

D. Hoppensteadt, J. Fareed, W. Jeske, 2005, Hematology/oncology clinics of North America.

Ticlopidine and Clopidogrel: Do They Have Direct Vascular Effects?

J. Fareed, H. Messmore, W. Wehrmacher, 1997 .

Stasis Ulcers Refractory to Therapy—Accelerated Healing by Treatment With Clopidogrel ± Dalteparin: A Preliminary Report

R. Bick, Ronald G. Scott, 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Cancer-associated thrombosis: focus on extended therapy with dalteparin.

Rodger L Bick, R. Bick, 2006, The journal of supportive oncology.

Recurrent Miscarriage Syndrome due to Blood Coagulation Protein/Platelet Defects: Prevalence, Treatment and Outcome Results

R. Bick, 2000, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Factor V: a Simplified One-Stage Assay using a Stabilized Artificial Substrate

R. Bick, E. Shanbrom, R. Bishop, 1973 .

Deep vein thrombosis. Diagnosis and management.

R. Bick, W. Baker, 1994, The Medical clinics of North America.

Molecular markers of hemostatic activation. Implications in the diagnosis of thrombosis, vascular, and cardiovascular disorders.

D. Hoppensteadt, J. Fareed, H. Messmore, 1995, Clinics in laboratory medicine.

Clinical Implications of Molecular Markers in Hemostasis and Thrombosis

R. Bick, 1984, Seminars in thrombosis and hemostasis.

Syndromes Associated with Hyperfibrino(GENO)Lysis

R. Bick, 2019, Disseminated Intravascular Coagulation and Related Syndromes.

Primary Hyperfibrino(Geno)Lytic Syndromes

G. Murano, R. Bick, 2019, Basic Concepts of Hemostasis and Thrombosis.

Clinical use of intrapulmonary heparin.

R. Bick, E. Ross, 1985, Seminars in thrombosis and hemostasis.

Proficient and Cost-Effective Approaches for the Prevention and Treatment of Venous Thrombosis and Thromboembolism

R. Bick, 2000, Drugs.

Understanding the Antiphospholipid-Thrombosis Syndromes

R. Bick, K. Mclntyre, D. Ancypa, 1995 .

Therapy for Venous Thrombosis: Guidelines for a Competent and Cost-effective Approach

R. Bick, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

IN-VIVO PLATELET INHIBITION BY PIRACETAM

R. Bick, 1979, The Lancet.

Differentiation of low-molecular-weight heparins: impact on the future of the management of thrombosis.

D. Hoppensteadt, J. Fareed, Q. Ma, 2004, Seminars in thrombosis and hemostasis.

Are the Current Guidelines for the Acceptance of Generic Low Molecular Weight Heparins Adequate?

J. Fareed, R. Bick, 2003, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Antiphospholipid syndrome in pregnancy.

R. Bick, 2008, Hematology/oncology clinics of North America.

Prothrombin G20210A Gene Mutation, Heparin Cofactor II Defects, Primary (Essential) Thrombocythemia, and Thrombohemorrhagic Manifestations

E. Frenkel, R. Bick, E. Frenkel, 1999, Seminars in thrombosis and hemostasis.

Alterations of Hemostasis Associated With Malignancy: Etiology, Pathophysiology, Diagnosis and Management

R L Bick, R. Bick, 2008, Seminars in thrombosis and hemostasis.

Vascular Damage Correlates between Heparin-Induced Thrombocytopenia and the Antiphospholipid Syndrome

J. A. Robinson, D. Hoppensteadt, J. Walenga, 1999 .

Generic Low Molecular Weight Heparins: A Significant Dilemma

S. Mousa, H. Nader, J. Fareed, 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Free‐Standing Cancer Centers: Rationale for Improving Cancer Care Delivery

H. Brereton, J. Lokich, J. Byfield, 1989, American journal of clinical oncology.

Sticky Platelet Syndrome: A Common Cause of Unexplained Arterial and Venous Thrombosis

R. Bick, 1998 .

Development of a Synthetic Heparin Pentasaccharide: Fondaparinux.

M. Samama, J. Fareed, W. Jeske, 2002, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Recurrent miscarriage: causes, evaluation, and treatment.

J. Madden, R. Bick, A. Toofanian, 1998, Medscape women's health.

Anemia of malignancy.

R. Bick, 1995, Advances in experimental medicine and biology.

The antiphospholipid and thrombosis (APL-T) syndromes. Clinical and laboratory correlates.

R. Bick, D. Ancypa, 1995, Clinics in laboratory medicine.

Vascular damage correlates between heparin-induced thrombocytopenia and the antiphospholipid syndrome.

D. Hoppensteadt, J. Robinson, J. Walenga, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Antiphospholipid antibodies in coronary artery disease: a review.

R. Bick, W. Baker, 1994, Seminars in thrombosis and hemostasis.

Assay Dependent Variations in the Anticoagulant and Protamine Sulfate Neutralization Profiles of Generic Copies of Enoxaparin.

D. Hoppensteadt, J. Fareed, W. Jeske, 2006 .

Hereditary and acquired thrombophilia. Part I. Preface.

R. Bick, 1999, Seminars in thrombosis and hemostasis.

Clinical Hemostasis Practice: The Major Impact of Laboratory Automation

R. Bick, 1983, Seminars in thrombosis and hemostasis.

Current Status of Thrombosis: A Multidisciplinary Medical Issue and Major American Health Problem—Beyond the Year 2000

J. Fareed, R. Bick, 1997 .

Disseminated lntravascular Coagulation and Related Syndromes: Etiology, Pat hop h ysi olog y, Di ag nosis, and Management

R. Bick, 2006 .

Iron Deficiency Anemia

R. Bick, W. Baker, 1990 .

P. Kronick, J. Fareed, R. Bick, 1981, Thrombosis and Haemostasis.

Thrombotic thrombocytopenic purpura. An extended editorial.

R. Bick, R. Nalbandian, R. Henry, 2008, Seminars in thrombosis and hemostasis.